PINK ETF — Holdings & Analysis
The Simplify Health Care ETF (PINK) is an equity ETF with $0.25B in assets under management and an expense ratio of 0.51%. PINK focuses on multi-cap exposure to innovative companies within the healthcare sector, including biotech, medtech, and gene therapy. A key differentiator is its 100% pro bono structure, with net profits donated to the Susan G. Komen foundation annually, making it a unique investment option for those seeking both financial returns and social impact.
Simplify Health Care ETF (PINK) ETF — Price, Holdings & Analysis
ETF Overview
Risk Metrics
Expense Ratio
Top Holdings
- Align Technology Inc (ALGN): 8.11%
- Eli Lilly and Co (LLY): 7.00%
- Chugai Pharmaceutical Co Ltd (4519.T): 5.20%
- Regeneron Pharmaceuticals Inc (REGN): 5.01%
- Novo Nordisk AS ADR (NVO): 4.66%
- AbbVie Inc (ABBV): 4.50%
- Johnson & Johnson (JNJ): 4.48%
- Biohaven Ltd (BHVN): 4.13%
- Jazz Pharmaceuticals PLC (JAZZ): 3.92%
- Amgen Inc (AMGN): 3.88%
Sector Allocation
- Healthcare: 95.0%
- Industrials: 5.0%
- United States: 81.4%
- Denmark: 6.7%
- Japan: 5.3%
- Ireland: 4.0%
- United Kingdom: 2.1%
- Other: 0.5%
- France: 0.0%
Dividend Yield
- <a href="/etf/xlf">State Street Financial Select Sector SPDR ETF (XLF)</a> — 0.08% expense ratio
- <a href="/etf/xlk">State Street Technology Select Sector SPDR ETF (XLK)</a> — 0.08% expense ratio
- <a href="/etf/eem">iShares MSCI Emerging Markets ETF (EEM)</a> — 0.72% expense ratio
- <a href="/etf/spy">State Street SPDR S&P 500 ETF Trust (SPY)</a> — 0.09% expense ratio
- <a href="/etf/rwde">Direxion MSCI Developed Over Emerging Markets ETF (RWDE)</a> — 0.53% expense ratio
- <a href="/etf/fine">Themes European Luxury ETF (FINE)</a> — 0.35% expense ratio
- <a href="/etf/mj">Amplify Alternative Harvest ETF (MJ)</a> — 0.75% expense ratio
- <a href="/etf/defa">iShares Adaptive Currency Hedged MSCI EAFE ETF (DEFA)</a> — 0.35% expense ratio
- <a href="/etf/suri">Simplify Propel Opportunities ETF (SURI)</a> (Equity) — 2.82% ER
- <a href="/etf/maxi">Simplify Bitcoin Strategy PLUS Income ETF (MAXI)</a> (Alternatives) — 1.00% ER
- <a href="/etf/foxy">Simplify Currency Strategy ETF (FOXY)</a> (Alternatives) — 0.81% ER
- <a href="/etf/aggh">Simplify Aggregate Bond ETF (AGGH)</a> (Fixed Income) — 0.55% ER
- <a href="/etf/sdmf">Simplify DBi CTA Managed Futures Index ETF (SDMF)</a> (Alternatives) — 0.35% ER
- <a href="/etf/sbil">Simplify Government Money Market ETF (SBIL)</a> (Fixed Income) — 0.15% ER
Risk Metrics
- Beta: 0.87
常见问题
What is PINK and what does it track?
The Simplify Health Care ETF (PINK) is an equity ETF that seeks long-term capital appreciation by investing in groundbreaking and innovative companies within the healthcare sector. This includes companies involved in biotech, medtech, gene therapy, and other fast-growing healthcare-related areas. PINK stands out as the first 100% pro bono ETF focused on the healthcare sector, donating its net profits annually to the Susan G. Komen foundation. The fund's portfolio is actively managed and includes a diverse range of healthcare companies, aiming to capture growth opportunities within the industry.
What is the expense ratio for PINK?
The Simplify Health Care ETF (PINK) has an expense ratio of 0.51%. This means that for every $10,000 invested, $51 is used to cover the fund's operating expenses annually. While this is higher than some broad market ETFs, it is important to consider the specialized focus of PINK on innovative healthcare companies. When evaluating the expense ratio, the may be worth researching potential returns and the unique philanthropic aspect of the fund, which donates net profits to the Susan G. Komen foundation.
What are the top holdings in PINK?
The Simplify Health Care ETF (PINK) has a concentrated portfolio of healthcare companies. As of 2026-03-15, the top holdings include Align Technology Inc (8.11%), Eli Lilly and Co (7.00%), and Chugai Pharmaceutical Co Ltd (5.20%). Regeneron Pharmaceuticals Inc (5.01%) and Novo Nordisk AS ADR (4.66%) also represent significant portions of the fund's assets. These companies reflect PINK's focus on innovative and growth-oriented businesses within the healthcare sector.
Is PINK a good long-term investment?
Determining whether the Simplify Health Care ETF (PINK) is a suitable long-term investment depends on individual investment goals and risk tolerance. PINK focuses on the healthcare sector, specifically innovative companies in biotech, medtech, and gene therapy. The fund has an expense ratio of 0.51% and a beta of 0.87. Its unique pro bono structure, donating net profits to the Susan G. Komen foundation, may appeal to socially conscious investors. Past performance does not guarantee future results.
How does PINK compare to similar ETFs?
The Simplify Health Care ETF (PINK) distinguishes itself from other healthcare ETFs primarily through its philanthropic mission, donating net profits to the Susan G. Komen foundation. In terms of expense, PINK's expense ratio is 0.51%. While some healthcare ETFs may have lower expense ratios, PINK's unique structure and active management may justify the cost for some investors. With AUM of $0.25B, PINK is smaller than some of the more established healthcare ETFs. Investors should weigh these factors when comparing PINK to its peers.
Does PINK pay dividends?
As of 2026-03-15, the Simplify Health Care ETF (PINK) has a dividend yield of 0.00%. This indicates that the fund does not currently distribute dividends to its shareholders. PINK's investment strategy focuses on capital appreciation through investments in growth-oriented healthcare companies rather than generating income through dividends. Investors seeking dividend income may need to consider alternative investment options.